"Syntara has another four trials that are running all with internally developed drugs. To the best of our knowledge, Syntara is the only ASX listed company, other than CSL, that have an internal R&D capability that has generated multiple clinical stage candidates"
this is something I didn't know until now.
SNT - General Discussions, page-114
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.003(6.67%) |
Mkt cap ! $57.67M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.5¢ | 4.2¢ | $37.11K | 834.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 244513 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 220000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| SNT (ASX) Chart |